Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nokian Tyres OYJ Unsponsored Finland ADR NKRKY

Nokian Tyres plc is a Finland-based company active in the tire manufacturing industry. The Company diversifies its activities into three main business segments: Passenger Car Tires, Heavy Tires and Vianor. The Passenger Car Tires business segment comprises the development and production of summer and winter tires for cars and vans. The Heavy Tires business segment comprises tires for forestry machinery, special tires and agricultural machinery, tractors and industrial machinery. The Vianor business segment is specialized in car maintenance and tyre services. The tyre products cover all sorts of tyres for passenger cars, vans and trucks, as well as heavy specialist machinery. In addition to Nokian Tyres’ products, Vianor also represents and sells other tyre brands. The Company diversifies its activities into geographical segments: Finland, Sweden, Norway, Other Europe and North America.


PINL:NKRKY - Post by User

Post by CoressPringson Jun 03, 2022 4:07am
39 Views
Post# 34728677

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance



FSD Pharma ready to proceed with Phase 2 clinical trial of FSD-201 as soon as it gets clearance
 
FSD Pharma Inc CEO Anthony Durkacz told Proactive that the company is ready to proceed with the planned Phase 2 clinical trial of its FSD-201 drug candidate as soon as it gets the go-ahead from the US Food and Drug Administration and Health Canada. That's after submitting Investigational New Drug (IND) applications to the two bodies this week. Armed with cash of about $50 million following the $16.4 million disposal of its former cannabis production facility in Ontario, Durkacz said FSD is also moving full-steam ahead on its two other drug candidates and may look for other opportunities. A special dividend may also be on the cards, he added.


<< Previous
Bullboard Posts
Next >>